Reference [12]
[12] FDA. Gabapentin and Pregabalin Drug Safety Communication. Respiratory safety warning; not a DXM study. Open publication
[12] FDA. Gabapentin and Pregabalin Drug Safety Communication. Respiratory safety warning; not a DXM study. Open publication